"discovery of novel helminth immunomodulatory proteins for autoimmune diseases"
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93018C00035
- Awardee
-
Celdara Medical, LLC UEI MMVKQXZUBMQ7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $598,006
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Pre-Solicitation · PHS20181 · Posted Jun 29, 2017
- Contract value 100% obligated
- $598,006.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, NH 03766, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $598,006 |
About this award
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, LLC, a small business biotechnology company. The $598,006 Firm Fixed Price contract supports Celdara Medical's research under the Small Business Innovation Research (SBIR) Program Phase I to discover novel helminth (parasitic worm) immunomodulatory proteins for the treatment of autoimmune diseases. The contract was set aside for participation by small businesses. Celdara Medical has received multiple federal contracts and grants from NIH, including for the development of vaccine adjuvants and treatments targeting infectious diseases, cancer, neurological disorders, and other unmet medical needs.
Quick answers
Who was awarded contract 75N93018C00035?
75N93018C00035 was awarded to Celdara Medical, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 31, 2018.
How much is contract 75N93018C00035 worth?
The government has obligated $598,006 on 75N93018C00035.
Was contract 75N93018C00035 competed?
The extent of competition for 75N93018C00035 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award